<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02836743</url>
  </required_header>
  <id_info>
    <org_study_id>1505-084-673</org_study_id>
    <nct_id>NCT02836743</nct_id>
  </id_info>
  <brief_title>Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic RBD: a Pilot Study</brief_title>
  <official_title>Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic REM Sleep Behavior Disorder: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate effect of slow-release melatonin (Circadin) on REM sleep behavior disorder.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators planned to administer low (2mg) and high (6mg) dose slow-release melatonin and
      the placebo for 4 weeks and evaluate Clinical Global Impression scale, RBD questionnaire,
      PSQI, Epworth sleepiness scale, and quality of life questionnaire (SF-36v2) before and after
      the treatment along with possible side effects and drug compliance.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">December 31, 2017</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in Clinical Global Impression scale</measure>
    <time_frame>baseline and 4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in RBDQ-HK score (RBD questionnaire-HK)</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sleep quality questionnaire</measure>
    <time_frame>after taking the treatment for 4 weeks</time_frame>
    <description>PSQI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleepiness questionnaire</measure>
    <time_frame>after taking the treatment for 4 weeks</time_frame>
    <description>Epworth sleepiness scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life questionnaire</measure>
    <time_frame>after taking the treatment for 4 weeks</time_frame>
    <description>SF-36 version 2.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Dream enactment behavior frequency described in sleep diary</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Drug adverse effect</measure>
    <time_frame>4 weeks</time_frame>
    <description>adverse events and reason for drug withdrawal</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>REM Sleep Behavior Disorder</condition>
  <arm_group>
    <arm_group_label>Circadin 2mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>low-dose (2mg) slow-release melatonin for 1 month.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Circadin 6mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>high-dose (6mg) slow-release melatonin for 1 month.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Administer placebo pills with identical morphology</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Circadin</intervention_name>
    <description>Slow-release melatonin</description>
    <arm_group_label>Circadin 2mg</arm_group_label>
    <arm_group_label>Circadin 6mg</arm_group_label>
    <other_name>slow-release melatonin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  REM sleep behavior disorder according to ICSD-3 criteria

          -  No cognitive deficit or symptom of Parkinsonism

          -  Those with written consent.

        Exclusion Criteria:

          -  who took medication (ex. clonazepam) for REM sleep behavior disorder

          -  with degenerative neurologic disorder (ex. Parkinson's disease, Multiple System
             Atrophy, Lewy-body dementia, etc.)

          -  who took medication that can affect REM sleep behavior disorder (anti-depressant:
             SSRI, TCA, MAO-inhibitor)

          -  who is unable to answer questionnaires

          -  who have hypersensitive reaction to medications

          -  Pregnant women or breastfeeding

          -  who are diagnosed with other parasomnia disorder

          -  with severe medical disorder (severe liver failure, respiratory failure, heart
             failure, malignant tumor, etc.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ki-Young Jung, M.D. Ph.D.</last_name>
    <phone>+82-2-2072-4988</phone>
    <email>jungky10@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jung-Ick Byun, M.D.</last_name>
    <phone>+82-2-440-6254</phone>
    <email>mr830611@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ki-Young Jung, professor</last_name>
      <phone>+82-2-2072-0694</phone>
      <email>jungky10@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Takeuchi N, Uchimura N, Hashizume Y, Mukai M, Etoh Y, Yamamoto K, Kotorii T, Ohshima H, Ohshima M, Maeda H. Melatonin therapy for REM sleep behavior disorder. Psychiatry Clin Neurosci. 2001 Jun;55(3):267-9.</citation>
    <PMID>11422870</PMID>
  </reference>
  <reference>
    <citation>Kunz D, Bes F. Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation. Mov Disord. 1999 May;14(3):507-11.</citation>
    <PMID>10348479</PMID>
  </reference>
  <reference>
    <citation>Boeve BF, Silber MH, Ferman TJ. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med. 2003 Jul;4(4):281-4.</citation>
    <PMID>14592300</PMID>
  </reference>
  <reference>
    <citation>Kunz D, Mahlberg R. A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. J Sleep Res. 2010 Dec;19(4):591-6. doi: 10.1111/j.1365-2869.2010.00848.x.</citation>
    <PMID>20561180</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 13, 2016</study_first_submitted>
  <study_first_submitted_qc>July 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2016</study_first_posted>
  <last_update_submitted>April 26, 2017</last_update_submitted>
  <last_update_submitted_qc>April 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Ki-Young Jung</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>REM sleep behavior disorder</keyword>
  <keyword>Melatonin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>REM Sleep Behavior Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

